Hepatitis Be Ag, Recombinant (HBeAg)

Catalog No : USB-H1915-14B
1331.07€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name Hepatitis Be Ag, Recombinant (HBeAg)
Catalog No USB-H1915-14B
Supplier’s Catalog No H1915-14B
Supplier US Biologicals
Source antigen Recombinant, E. coli
Reactivity
Cross reactivity
Applications
Molecular weight 43.9
Storage -20°C
Other names
Grade Highly Purified
Purity ~95% (10% PAGE coomassie staining). GS-4B Sepharose Affinity Purification.
Form Supplied as a liquid in 50mM Tris-HCl, pH 8.5, 8M urea, 10mM Beta-Mercaptoethanol. No preservative added.
Reactivity life 6 months
Note For reserch purpose only
Purity ~95% (10% PAGE coomassie staining). GS-4B Sepharose Affinity Purification.
Description Contains the HBe immunodominant region. Contains GST fusion partner. Immunoreactive with HBV positive sera. Hepatitis B e-antigen (HBeAg) is a viral protein associated with HBV infections. Unlike the surface antigen, the e-antigen is found in the blood only when there are viruses also present. When the virus goes into "hiding," the e-antigen will no longer be present in the blood. HBeAg is often used as a marker of ability to spread the virus to other people (infectivity). Measurement of e-antigen may also be used to monitor the effectiveness of HBV treatment; successful treatment will usually eliminate HBeAg from the blood and lead to development of antibodies against e-antigen (anti-HBe). There are some types (strains) of HBV that do not make e-antigen; these are especially common in the Middle East and Asia. In areas where these strains of HBV are common, testing for HBeAg is not very useful. Applications: Suitable for use in ELISA and Western Blot. Other applications not tested. Recommended Dilutions: Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 6 months after receipt at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.